Annual CFO
-$14.14 M
-$3.58 M-33.93%
31 December 2023
Summary:
CNS Pharmaceuticals annual cash flow from operations is currently -$14.14 million, with the most recent change of -$3.58 million (-33.93%) on 31 December 2023. During the last 3 years, it has fallen by -$6.82 million (-93.22%). CNSP annual CFO is now -1873.76% below its all-time high of -$716.40 thousand, reached on 31 December 2018.CNSP Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$6.80 M
-$5.15 M-312.02%
30 September 2024
Summary:
CNS Pharmaceuticals quarterly cash flow from operations is currently -$6.80 million, with the most recent change of -$5.15 million (-312.02%) on 30 September 2024. Over the past year, it has dropped by -$3.42 million (-101.40%). CNSP quarterly CFO is now -8122.49% below its all-time high of -$82.70 thousand, reached on 31 March 2019.CNSP Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$14.18 M
-$3.42 M-31.83%
30 September 2024
Summary:
CNS Pharmaceuticals TTM cash flow from operations is currently -$14.18 million, with the most recent change of -$3.42 million (-31.83%) on 30 September 2024. Over the past year, it has dropped by -$269.90 thousand (-1.94%). CNSP TTM CFO is now -17044.98% below its all-time high of -$82.70 thousand, reached on 31 March 2019.CNSP TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNSP Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -33.9% | -101.4% | -1.9% |
| 3 y3 years | -93.2% | -240.8% | -20.7% |
| 5 y5 years | -1873.8% | -1697.5% | -1215.4% |
CNSP Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -93.2% | at low | -312.0% | at low | -34.3% | at low |
| 5 y | 5 years | -1873.8% | at low | -1697.5% | at low | -1215.4% | at low |
| alltime | all time | -1873.8% | at low | -8122.5% | at low | <-9999.0% | at low |
CNS Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$6.80 M(+312.0%) | -$14.18 M(+31.8%) |
| June 2024 | - | -$1.65 M(-48.3%) | -$10.76 M(-14.0%) |
| Mar 2024 | - | -$3.19 M(+25.9%) | -$12.51 M(-11.5%) |
| Dec 2023 | -$14.14 M(+33.9%) | -$2.54 M(-24.9%) | -$14.14 M(+1.7%) |
| Sept 2023 | - | -$3.38 M(-0.8%) | -$13.91 M(+12.7%) |
| June 2023 | - | -$3.40 M(-29.5%) | -$12.35 M(+0.3%) |
| Mar 2023 | - | -$4.82 M(+109.3%) | -$12.31 M(+16.6%) |
| Dec 2022 | -$10.56 M(-22.0%) | -$2.31 M(+27.2%) | -$10.56 M(-8.1%) |
| Sept 2022 | - | -$1.81 M(-46.1%) | -$11.49 M(-1.6%) |
| June 2022 | - | -$3.36 M(+9.3%) | -$11.67 M(-12.3%) |
| Mar 2022 | - | -$3.08 M(-4.9%) | -$13.31 M(-1.7%) |
| Dec 2021 | -$13.54 M | -$3.24 M(+62.2%) | -$13.54 M(+15.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$2.00 M(-60.1%) | -$11.75 M(+6.5%) |
| June 2021 | - | -$5.00 M(+51.1%) | -$11.03 M(+25.7%) |
| Mar 2021 | - | -$3.31 M(+128.6%) | -$8.77 M(+19.9%) |
| Dec 2020 | -$7.32 M(+105.9%) | -$1.45 M(+13.6%) | -$7.32 M(-12.3%) |
| Sept 2020 | - | -$1.27 M(-53.6%) | -$8.35 M(+12.0%) |
| June 2020 | - | -$2.74 M(+47.8%) | -$7.45 M(+39.9%) |
| Mar 2020 | - | -$1.86 M(-25.1%) | -$5.33 M(+49.9%) |
| Dec 2019 | -$3.55 M(+396.0%) | -$2.48 M(+554.4%) | -$3.55 M(+229.7%) |
| Sept 2019 | - | -$378.30 K(-38.7%) | -$1.08 M(+54.1%) |
| June 2019 | - | -$616.90 K(+645.9%) | -$699.60 K(+745.9%) |
| Mar 2019 | - | -$82.70 K | -$82.70 K |
| Dec 2018 | -$716.40 K | - | - |
FAQ
- What is CNS Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals annual CFO year-on-year change?
- What is CNS Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals quarterly CFO year-on-year change?
- What is CNS Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals TTM CFO year-on-year change?
What is CNS Pharmaceuticals annual cash flow from operations?
The current annual CFO of CNSP is -$14.14 M
What is the all time high annual CFO for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high annual cash flow from operations is -$716.40 K
What is CNS Pharmaceuticals annual CFO year-on-year change?
Over the past year, CNSP annual cash flow from operations has changed by -$3.58 M (-33.93%)
What is CNS Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of CNSP is -$6.80 M
What is the all time high quarterly CFO for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high quarterly cash flow from operations is -$82.70 K
What is CNS Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, CNSP quarterly cash flow from operations has changed by -$3.42 M (-101.40%)
What is CNS Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of CNSP is -$14.18 M
What is the all time high TTM CFO for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high TTM cash flow from operations is -$82.70 K
What is CNS Pharmaceuticals TTM CFO year-on-year change?
Over the past year, CNSP TTM cash flow from operations has changed by -$269.90 K (-1.94%)